Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Véronique Lamarque

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Therapie|November 28, 2006
Risk management and monitoring methods for the future mother, embryo, fetus, and post-natal consequencesEvelyne Jacqz-Aigrain, Véronique Lamarque
Therapie|July 10, 2016
[Not Available]Evelyne Jacqz-Aigrain, Véronique Lamarque,
Therapie|July 10, 2016
[Not Available]Florence Tubach, Véronique Lamarque-Garnier, Anne Castot, et al.
Therapie|July 10, 2016
[Not Available]Véronique Lamarque, Louis Merle, Jean Paul Demarez, et al.
Therapie|October 22, 2008
Generics and substitution modalities: proposed methods for the evaluation of equivalence, traceability and pharmacovigilance reportingVéronique Lamarque, Louis Merle, Jean Paul Demarez, et al.
Therapie|August 20, 2011
Role of the post-marketing authorisation studies in drug risk surveillance: specifications and methodologiesFlorence Tubach, Véronique Lamarque-Garnier, Anne Castot, et al.
The Journal of Investigative Dermatology|January 25, 2003
Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort studyCarle F Paul, Vincent C Ho, Claire McGeown, et al.
Therapie|February 14, 2015
The European "clinical trial" regulation; relationship with the Jardé Act: a Giens workshopFrançois Lemaire, Brigitte Marchenay, Olivier Chassany, et al.
Therapie|July 10, 2016
[Not Available]François Lemaire, Brigitte Marchenay, Olivier Chassany, et al.
Therapie|March 14, 2018
Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databasesDriss Berdaï, Florence Thomas-Delecourt, Karine Szwarcensztein, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Therapie|November 28, 2006
Risk management and monitoring methods for the future mother, embryo, fetus, and post-natal consequencesEvelyne Jacqz-Aigrain, Véronique Lamarque
Therapie|July 10, 2016
[Not Available]Evelyne Jacqz-Aigrain, Véronique Lamarque,
Therapie|July 10, 2016
[Not Available]Florence Tubach, Véronique Lamarque-Garnier, Anne Castot, et al.
Therapie|July 10, 2016
[Not Available]Véronique Lamarque, Louis Merle, Jean Paul Demarez, et al.
Therapie|October 22, 2008
Generics and substitution modalities: proposed methods for the evaluation of equivalence, traceability and pharmacovigilance reportingVéronique Lamarque, Louis Merle, Jean Paul Demarez, et al.
Therapie|August 20, 2011
Role of the post-marketing authorisation studies in drug risk surveillance: specifications and methodologiesFlorence Tubach, Véronique Lamarque-Garnier, Anne Castot, et al.
The Journal of Investigative Dermatology|January 25, 2003
Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort studyCarle F Paul, Vincent C Ho, Claire McGeown, et al.
Therapie|February 14, 2015
The European "clinical trial" regulation; relationship with the Jardé Act: a Giens workshopFrançois Lemaire, Brigitte Marchenay, Olivier Chassany, et al.
Therapie|July 10, 2016
[Not Available]François Lemaire, Brigitte Marchenay, Olivier Chassany, et al.
Therapie|March 14, 2018
Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databasesDriss Berdaï, Florence Thomas-Delecourt, Karine Szwarcensztein, et al.
Pageof 2